In the long human effort to understand why bodies wear down, a new question has begun to take shape: whether medicines created to help people manage their weight and blood sugar might also slow the quiet clock within us. Drugs such as Ozempic and Wegovy have become familiar far beyond the clinic, and early research now hints that their influence may reach deeper than the scale. Such hints, offered by the companies that make the drugs, are a beginning rather than an answer, and the true measure of their promise will rest on whether independent eyes can see the same thing.
Weight-Loss Drugs May Slow Biological Ageing, Early Research Suggests
Biological age is an estimate of whether the body ages faster or slower than expected
Mark
So what is actually being claimed here?
Mimi
That some people on GLP-1 drugs like Ozempic and Wegovy showed biological-age markers that looked two to three years younger. The comparison was with people given a placebo.
Mark
What is biological age, exactly?
Mimi
It's an estimate of whether the body is ageing faster or slower than expected. Scientists look at DNA changes and protein levels to work it out.
Luke
Before we get carried away, who produced this research?
Mimi
It was presented by Novo Nordisk and Eli Lilly, the pharmaceutical companies behind these treatments.
Luke
Right, so it is company-presented, not independently confirmed. That matters.
Mark
Does it mean the drugs slow ageing?
Luke
Not yet. A shift in markers is not the same as people living longer or healthier lives. The reporting doesn't show that, and scientists say it isn't a breakthrough.
Mimi
The wording in the story is careful. Interest is high, but the results are preliminary.
Mark
What would change that?
Luke
Independent confirmation. The source doesn't say who is doing that work or when it might arrive, so that part is unknown.
Il Polso
- Early data suggests some patients on GLP-1 drugs show biological-age markers improving by two to three years, a claim that has drawn immediate attention.
- Results presented by Novo Nordisk and Eli Lilly have stirred interest, yet the source of the findings is the same companies that sell the drugs.
- Researchers are reading DNA and protein indicators together to judge whether the body is ageing faster or slower than expected, comparing treated patients against placebo groups.
- Scientists are holding back from calling it a breakthrough, and the scientific community is waiting for independent confirmation before ageing claims can stand.
In the long human effort to understand why bodies wear down, a new question has begun to take shape: whether medicines created to help people manage their weight and blood sugar might also slow the quiet clock within us. Drugs such as Ozempic and Wegovy have become familiar far beyond the clinic, and early research now hints that their influence may reach deeper than the scale. Such hints, offered by the companies that make the drugs, are a beginning rather than an answer, and the true measure of their promise will rest on whether independent eyes can see the same thing.
Researchers are now asking whether the drugs best known for helping people lose weight might also change how fast the body ages. Medications such as Ozempic and Wegovy have drawn worldwide attention for treating type 2 diabetes and obesity, and early research suggests their effects may reach beyond the bathroom scales.
Some patients taking these medications showed biological-age improvements equivalent to turning back the clock two to three years. Biological age is not the count of birthdays but an estimate of whether the body is ageing faster or slower than expected. Scientists build that estimate from DNA changes and levels of particular proteins, reading the markers together rather than trusting any single test.
The drugs belong to the GLP-1 receptor agonist class, which regulates blood sugar and reduces appetite. The data comes from Novo Nordisk and Eli Lilly, and the placebo comparison matters, since it suggests the shift was tied to treatment rather than the mere passing of time.
Yet the researchers are careful. Far from declaring a breakthrough in reversing ageing, they describe the findings as preliminary. Because the companies that make the drugs presented the results, independent confirmation is the next real test of whether the shift holds.
Researchers are now asking whether the drugs best known for helping people lose weight might also change how fast the body ages. Medications such as Ozempic and Wegovy have drawn worldwide attention for treating type 2 diabetes and obesity. Early research suggests their effects may reach beyond the bathroom scales.
The central finding is modest in wording but striking in implication. Some patients taking these medications showed improvements in biological-age measurements equivalent to turning back the clock by two to three years. Biological age is different from the number of birthdays a person has had. It is an estimate of whether the body is ageing faster or slower than expected.
Scientists arrive at that estimate by looking at indicators including changes in DNA and levels of particular proteins. Those markers are read together to build a picture of how the body is ageing, rather than relying on a single test.
The drugs belong to a class known as GLP-1 receptor agonists. They help regulate blood sugar, reduce appetite and support weight management, which is why they have become so widely used for diabetes and obesity.
The data comes from research presented by two pharmaceutical companies, Novo Nordisk and Eli Lilly. In that research, some people receiving GLP-1 treatments recorded improvements in biological-age markers compared with people who were given a placebo. The placebo comparison matters, because it suggests the shift was linked to the treatment rather than simply to the passage of time.
Still, the researchers and those reporting on the work are careful about how far the findings can be taken. Scientists are far from declaring a breakthrough in reversing ageing, even though the results have generated considerable interest. The findings are preliminary, and independent confirmation is needed before anyone can make claims about ageing.
That caution is the thing to watch. The results were presented by the companies that make the drugs, so confirmation from independent researchers is the next test of whether a two-to-three-year shift in biological-age markers holds up.
Citazioni salienti
Scientists are far from declaring a breakthrough in reversing ageing, and independent confirmation is needed.— Paraphrase of scientists' caution, as reported by Redland Bayside News
Vuoi la storia completa?
Leggi l'originale su Redland Bayside News ↗
Health & Medicine